主动脉内球囊反搏后发生血小板减少症的危险因素及对近期预后影响的临床分析

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo analyze and explore the risk factors of thrombocytopenia and its influence on the short-term prognosis in patients undergoing intra-aortic balloon pump(IABP)counterpulsation.Methods 108 patients who received IABP in our hospital from March 2014 to March 2016 were selected and divided into the thrombocytopenia group(74 cases)and the non thrombocytopenia group(34 cases)according to whether thrombocytopenia occurred.The platelet and clinical features of the selected patients were analyzed retrospectively.Results Thrombocytopenia occurred in 74 patients(68.5%,74/108),and the degree of thrombocytopenia increased with the duration of IABP support.Multi factor Logistic regression analysis showed that baseline platelet count was the only influential factor in this study(P＜0.01),and there was no significant difference between the two groups in mortality and 30 days re-admission rate(P＞0.05).Conclusion The degree of thrombocytopenia is related to the duration of IABP support.Lower baseline platelet count is independent risk factor for thrombocytopenia,which is not affect the short-term prognosis.

Key words： Intra-aortic balloon pump Thrombocytopenia Risk factors Prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LUO Jie-hong
	LIU Jin-guang
	SHEN Yuan-sheng

Cite this article:

LUO Jie-hong,LIU Jin-guang,SHEN Yuan-sheng. Clinical analysis of the risk factors and short-term prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pump counterpulsation[J]. 中国当代医药, 2018, 25(7): 17-20.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I7/17

[1]	Vonderheide RH，Thadhani R，Kuter DJ.Association of thrombocytopenia with the use of intra-aortic balloon pumps[J].Am J Med，1998，105（1）：27-32.
[2]	Roy SK，Howard EW，Panza JA，et al.Clinical implications of thrombocytopenia among patients undergoing intra-aortic balloon pump counterpulsation in the coronary care unit[J].Clin Cardiol，2010，33（1）：30-35.
[3]	Vales L，Kanei Y，Ephrem G，et al.Intra-aortic balloon pump use and outcomes with current therapies[J].J Invasive Cardiol，2011，23（3）：116-119.
[4]	周贻军，赵亚男，刘映峰，等.主动脉内球囊反搏介导血小板减少的临床分析[J].岭南心血管病杂志，2013，19（3）：269-271.
[5]	吴铿，何松坚，叶少强，等.主动脉内球囊反搏治疗急性冠脉综合征的临床应用研究[J].中国实用医药，2011，6（35）：6-9.
[6]	Bream-Rouwenhorst HR，Hobbs RA，Horwitz PA.Thrombocytopeniainpatientstreatedwithheparin，combinationantiplatelet therapy，and intra-aortic balloon pump counterpulsation[J].J Interv Cardiol，2008，21（4）：350-356.
[7]	张宪芬，高文根，孟海英，等.冠心病患者应用IABP后血小板减少的临床分析[J].中国心血管病研究，2015，13（4）：346-349.
[8]	杨辉，肖平喜，程久佩，等.385例高危急性冠脉综合征患者的 IABP 相关并发症分析[J].中国医学创新，2012，9（33）：125-126.
[9]	Schiariti M，Saladini P，Cuturello D，et al.Decline in platelet count and long-term post-PCI ischemic events：implication of the intra-aortic balloon pump[J].Vascul Pharmacol，2014，60（1）：25-31.
[10]	李江，刘文娴，朱佳佳，等.急性心肌梗死患者应用主动脉内球囊反搏治疗时血小板减少的临床分析[J].山东医药，2012，52（4）：17-18，21.
[11]	粱林宝，程国栋，朱春磊，等.主动脉内球囊反搏的抗凝体会[J].中国心血管病研究，2014，12（3）：205-207.
[12]	Investigators TR.Effects of platelet glycoprotein Ⅱb/Ⅲa blockade with tirofiban on adverse cardiac events in patients withunstableanginaoracutemyocardialinfarctionundergoing coronaryangioplasty.TheRESTOREInvestigatorsRandomized Efficacy Study of Tirofiban for Outcomes and Restenosis[J].Circulation，1997，96（5）：1445-1453.
[13]	刘怡.替罗非班联合IABP对冠脉复杂病变患者PCI术后的近期疗效观察[J].山东大学学报（医学版），2014，52（11）：45-48.
[14]	申红远，梁伟，汤喆，等.替罗非班致血小板减少5例[J].解放军医学院学报，2014，35（6）：578-580，592.
[15]	Park S，Lee J，Lee SY，et al.Acute profound thrombocytopenia after using abciximab for no-reflow during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J].Korean Circ J，2013，43（8）：557-560.
[16]	耿涛，宋志远，王炳勋，等.围手术期替罗非班应用对行DES置入老年冠心病患者出血、血小板减少及MACE发生风险的影响[J].中国医院药学杂志，2017，37（4）：380-382.
[17]	经子兰，任丽丽，赵昕，等.主动脉内球囊反搏辅助治疗冠心病合并慢性肾脏疾病的PCI患者临床疗效观察[J].解放军医学杂志，2015，40（4）：266-270.
[18]	Yadav M，Généreux P，Giustino G，et al.Effect of baseline thrombocytopenia on ischemic outcomes in patients with acute coronary syndromes who undergo percutaneous coronary intervention[J].Can J Cardiol，2016，32（2）：226-233.